- Joined
- 25 August 2004
- Posts
- 390
- Reactions
- 0
Couldn't see any posts on this so here goes
AFAIK
briefly: BTA get a royalty of a drug manufactured by GSK called relenza, which is one of 2 drugs which is effective in treating bird flu and suitable for stock piling .
BTA is currently sueing GSK for not adequately
promoting relenza for the amount of 308m - 400m | next step is mediation phase that occurs 25 november, I'm guessing this is where you migth settle out of court? BTA has a market cap of roughly 120m
BTA case must be looking alot more solid now since everyone is desperate to stockpile in case of a bird flu outbreak..
not to long ago BTA were trading at 50c first they announced reports of germany stockpiling relenza then a few days later confirmed it.
over the weekend thier was press about holland also stockpiling relenza, bta announced this to the market monday where yet to have a confirmation.
i was going to sell my holding today if it weakened around 95 and didnt look like it would hold but buyers kept coming in. I'm presuming traders have the same reluctance to sell that i do knowing thiers a confirmation with order quantities to come. Also new orders could come in at any time. Everyone is paniced about bird flu - its such hypy goodness. Even thought this is a bio in a neglected sector BTA keeps chomping on
It seems that USA is also possibly stockpiling relenza, bta heven't mentioned this yet so its only speculation.
I'm trying to pick an exit but i'd guess the TA is looking good for another run north tommorow
the fact that all these potential orders are looming and the massive amounts of bird flu in the press is enough to keep people from taking profits, loks like agood combination of TA FA and the best of all hype!![Smile :) :)](data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7)
the major problem is the demand for stock piling is so great that production needs to be increased greatly...
I've been camping this for the retrace but it hasn't come yet.. anyone else following
AFAIK
briefly: BTA get a royalty of a drug manufactured by GSK called relenza, which is one of 2 drugs which is effective in treating bird flu and suitable for stock piling .
BTA is currently sueing GSK for not adequately
promoting relenza for the amount of 308m - 400m | next step is mediation phase that occurs 25 november, I'm guessing this is where you migth settle out of court? BTA has a market cap of roughly 120m
BTA case must be looking alot more solid now since everyone is desperate to stockpile in case of a bird flu outbreak..
not to long ago BTA were trading at 50c first they announced reports of germany stockpiling relenza then a few days later confirmed it.
over the weekend thier was press about holland also stockpiling relenza, bta announced this to the market monday where yet to have a confirmation.
i was going to sell my holding today if it weakened around 95 and didnt look like it would hold but buyers kept coming in. I'm presuming traders have the same reluctance to sell that i do knowing thiers a confirmation with order quantities to come. Also new orders could come in at any time. Everyone is paniced about bird flu - its such hypy goodness. Even thought this is a bio in a neglected sector BTA keeps chomping on
It seems that USA is also possibly stockpiling relenza, bta heven't mentioned this yet so its only speculation.
I'm trying to pick an exit but i'd guess the TA is looking good for another run north tommorow
the fact that all these potential orders are looming and the massive amounts of bird flu in the press is enough to keep people from taking profits, loks like agood combination of TA FA and the best of all hype!
the major problem is the demand for stock piling is so great that production needs to be increased greatly...
I've been camping this for the retrace but it hasn't come yet.. anyone else following